Improving transportation solutions for patients needing dialysis
MOBILIZE: Mobility & Transportation Solutions to Improve Hemodialysis Access
This study is looking for ways to help people with end-stage kidney disease get to their hemodialysis appointments more easily, so they don’t miss treatments that are crucial for their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11143927 on NIH RePORTER |
What this research studies
This research focuses on addressing the transportation challenges faced by individuals with end-stage kidney disease (ESKD) who require regular hemodialysis. Many patients miss or delay their treatments due to a lack of reliable transportation, which can lead to serious health consequences. The project aims to develop and evaluate innovative mobility and transportation solutions to ensure that patients can consistently access their dialysis appointments. By understanding the social and community factors that affect healthcare access, the research seeks to create effective interventions that improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with end-stage kidney disease who rely on hemodialysis and face transportation barriers.
Not a fit: Patients who do not require hemodialysis or have reliable transportation to their medical appointments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance access to dialysis for patients, reducing missed appointments and improving overall health outcomes.
How similar studies have performed: Previous research has shown that addressing transportation barriers can improve healthcare access and outcomes, indicating a promising approach for this project.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Razon, Na'amah — University of California at Davis
- Study coordinator: Razon, Na'amah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.